InvestorsHub Logo
Followers 8
Posts 389
Boards Moderated 0
Alias Born 02/12/2009

Re: mojojojo post# 70407

Wednesday, 11/09/2011 10:01:00 AM

Wednesday, November 09, 2011 10:01:00 AM

Post# of 345952
Good points Mojo. I decided to check on this to remind me exactly how the two trials were structured. I thought that one was an "open label" and the other double blinded. In fact that seems to be the case. The one that is open label is at this link:

http://clinicaltrials.gov/ct2/show/NCT01160601

However, I'm confused on the actual structure of the trial based on this description from the link info:


"Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: A Randomized, Open-Label, Phase 2 Trial of Paclitaxel/Carboplatin With or Without Bavituximab in Patients With Previously Untreated Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer"

Can someone explain the meaning of "open label" and how it is applied in a "randomized" trial? I thought open label meant you knew what drug you were getting. Does random open label mean that they randomly select which patients get which treatment but whatever treatment arm they are randomly selected for the patients know what the treatment is?

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News